A cannabis testing facility in California has detected hydrogen cyanide in black market-sold cartridges.
The news, which was first reported by NBC News, has surfaced amidst the vape-lung crisis that...
New Frontier Data recently published a report on U.S. cannabis industry trends and predictions.
The cannabis research company – which is based in Washington D.C. – unveiled an intriguing insight...
An impressive $3 million will be invested into CBD research, following the approval of a grant by the U.S. National Institutes of Health (NIH).
The money will be funneled into numerous studies exploring...
Did you know that Attention Deficit Hyperactivity Disorder (ADHD) is one of the most commonly diagnosed disorders in children? Statistics show that approximately 5-7 percent of children and adolescents...
The CBD market is growing. A unique cannabinoid that harbors potential as a treatment for an ever-growing list of ailments and chronic conditions, 'cannabidiol' is a therapeutic powerhouse.
CBD may...
The rules for Jamaica's Medical cannabis exports are expected to be finalized within the next few weeks. This news comes following an announcement made by Agriculture Minister Audley Shaw.
Medical cannabis...
On Friday, September 20, lawmakers in Wisconsin introduced a medical cannabis bill that would permit patients’ access to pharmaceutical-grade products, so long as they register for enrolment with the...
A vote set to take place in November 2020 could result in adult-use cannabis being legalized throughout New Zealand.
The news comes after Prime Minister Jacinda Ardern revealed his plans to host a...
Cannabidiol is making its mark on the United Kingdom, with data indicating that the U.K. CBD market is currently overshadowing two significant segments of the health and wellness markets – Vitamin C...
Athletes and fitness fanatics are swapping workout supplements for CBD. An influx of CBD products are entering the market following the removal of this non-psychoactive cannabinoid from the list of banned...
British drugs company GW Pharmaceuticals celebrated approval for its cannabinoid-based epilepsy medicine EPIDYOLEX® back in June 2018 in the United States.
Now, EPIDYOLEX has also gained approval...
If things go to plan for a group of cannabis advocates in Massachusetts, the state could soon transform into a haven for cannabis culture.
An advisory panel recently voted 5 to 2 in an effort that...
